• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Australian regulators to take GI Dynamics EndoBarrier off the market

Australian regulators to take GI Dynamics EndoBarrier off the market

September 15, 2016 By Fink Densford

GI DynamicsGI Dynamics (ASX:GID) said it received notice from the Australian Therapeutic Goods Administration that it’s pulling the EndoBarrier device off the market Down Under effective Oct. 12.

The EndoBarrier device is a plastic gut sleeve designed to prevent the absorption of nutrients from food as it exits the stomach and enters the intestinal tract to treat Type II diabetes and obesity.

GI Dynamics said that yesterday it received “formal notification from the TGA” that the device’s clearance had been cancelled and that the company will not be permitted to supply the device in Australia.

Lexington, Mass.-based GI Dynamics said in a regulatory filing that it received notice that the “inclusion of the EndoBarrier device on the Australian Register of Therapeutic Goods (ARTG) may be cancelled” earlier this week.

The company said it has been in “ongoing communication” with the TGA over compliance-related matters, and has submitted all information as requested.

The notice comes a month after the company said it’s hoping to make another run at FDA approval for the flagship EndoBarrier after its 1st try failed last year.

In a presentation accompanying the release of its 2nd-quarter numbers, the medical device company said it’s busy repairing its relationship with the FDA and plans to finalize a bid for another investigational device exemption during the 1st half of 2017; GI Dynamics said it hopes to begin enrollment in the IDE trial by the end of June 2017.

A higher-than-expected rate of liver abscesses forced the halt of a U.S. trial last year.

The company managed to pare its Q2 losses despite a more than 50% top-line plunge, thanks in part to a 30% workforce cut initiated by new CEO Scott Schorer, a medical device veteran with stints as an executive or advisor at a raft of companies under his belt. Losses were down -62.0% to -$3.9 million, or -41 per share, on sales of $132,000 for the 3 months ended June 30, compared with the same period last year.

Filed Under: Diabetes, Regulatory/Compliance, Weight loss Tagged With: Australia Therapeutic Goods Administration, GI Dynamics

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy